Literature DB >> 17318233

Suppression of TH2-type allergic reactions by helminth infection.

Padraic G Fallon1, Niamh E Mangan.   

Abstract

There is no immunological mechanism to adequately explain the sudden epidemic in allergies noted in the last 30 years in developed countries. The reduction in the development of allergic disorders observed in individuals infected with parasitic helminths, however, supports a possible role for worms in suppressing allergies. Helminths regulate the immunity of the host to ensure a mutually beneficial environment for the survival of both the parasite and the host. This interplay between helminths and allergic responses raises fundamental questions in immunobiology. Harnessing current mechanistic studies for translational research into helminth infections and atopy might have potential for the identification of novel biomarkers, and even therapeutics, in allergic diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17318233     DOI: 10.1038/nri2039

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  70 in total

1.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: induction and control of regulatory T cells in the gastrointestinal tract: consequences for local and peripheral immune responses.

Authors:  Y Belkaid; O Liesenfeld; R M Maizels
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

2.  Schistosoma mansoni Worm Infection Regulates the Intestinal Microbiota and Susceptibility to Colitis.

Authors:  Achilleas Floudas; Gabriella Aviello; Christian Schwartz; Ian B Jeffery; Paul W O'Toole; Padraic G Fallon
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

Review 3.  Microbial control of regulatory and effector T cell responses in the gut.

Authors:  Timothy Hand; Yasmine Belkaid
Journal:  Curr Opin Immunol       Date:  2010-02-18       Impact factor: 7.486

4.  At homeostasis filarial infections have expanded adaptive T regulatory but not classical Th2 cells.

Authors:  Simon Metenou; Benoit Dembele; Siaka Konate; Housseini Dolo; Siaka Y Coulibaly; Yaya I Coulibaly; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Dramane Sanogo; Salif S Doumbia; Sekou F Traoré; Siddhartha Mahanty; Amy Klion; Thomas B Nutman
Journal:  J Immunol       Date:  2010-03-31       Impact factor: 5.422

5.  Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria/malaria-coinfected population.

Authors:  Simon Metenou; Benoit Dembélé; Siaka Konate; Housseini Dolo; Siaka Y Coulibaly; Yaya I Coulibaly; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Dramane Sanogo; Salif S Doumbia; Marissa Wagner; Sekou F Traoré; Amy Klion; Siddhartha Mahanty; Thomas B Nutman
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

Review 6.  Helminth-derived immunomodulators: can understanding the worm produce the pill?

Authors:  William Harnett; Margaret M Harnett
Journal:  Nat Rev Immunol       Date:  2010-03-12       Impact factor: 53.106

7.  Excretory/secretory proteome of the adult developmental stage of human blood fluke, Schistosoma japonicum.

Authors:  Feng Liu; Shu-Jian Cui; Wei Hu; Zheng Feng; Zhi-Qin Wang; Ze-Guang Han
Journal:  Mol Cell Proteomics       Date:  2009-03-18       Impact factor: 5.911

8.  Allergic Sensitization Underlies Hyperreactive Antigen-Specific CD4+ T Cell Responses in Coincident Filarial Infection.

Authors:  Pedro H Gazzinelli-Guimarães; Sandra Bonne-Année; Ricardo T Fujiwara; Helton C Santiago; Thomas B Nutman
Journal:  J Immunol       Date:  2016-08-26       Impact factor: 5.422

Review 9.  Parasitic helminths: new weapons against immunological disorders.

Authors:  Yoshio Osada; Tamotsu Kanazawa
Journal:  J Biomed Biotechnol       Date:  2010-02-10

Review 10.  Chronic helminth infections protect against allergic diseases by active regulatory processes.

Authors:  Hermelijn H Smits; Bart Everts; Franca C Hartgers; Maria Yazdanbakhsh
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.